Contrast-enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema (CASTLE) Study
Latest Information Update: 23 Aug 2024
At a glance
- Drugs Perflutren (Primary) ; Perflutren (Primary) ; Sulfur hexafluoride (Primary)
- Indications Lymphoedema
- Focus Diagnostic use
- Acronyms CASTLE
- 21 Aug 2024 Status changed from active, no longer recruiting to completed.
- 15 May 2024 Planned number of patients changed from 24 to 26.
- 19 Mar 2024 Planned End Date changed from 1 Mar 2024 to 30 Jun 2024.